SynthesisDiabetes, obesity & metabolism2012

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme.

B Zinman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.